{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T02:09:46Z","timestamp":1782871786877,"version":"3.54.5"},"reference-count":177,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2022,5,20]],"date-time":"2022-05-20T00:00:00Z","timestamp":1653004800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Neuronal ceroid lipofuscinoses (NCLs) are a group of rare, inherited, neurodegenerative lysosomal storage disorders that affect children and adults. They are traditionally grouped together, based on shared clinical symptoms and pathological ground. To date, 13 autosomal recessive gene variants, as well as one autosomal dominant gene variant, of NCL have been described. These genes encode a variety of proteins, whose functions have not been fully defined; most are lysosomal enzymes, transmembrane proteins of the lysosome, or other organelles. Common symptoms of NCLs include the progressive loss of vision, mental and motor deterioration, epileptic seizures, premature death, and, in rare adult-onset cases, dementia. Depending on the mutation, these symptoms can vary, with respect to the severity and onset of symptoms by age. Currently, all forms of NCL are fatal, and no curative treatments are available. Herein, we provide an overview to summarize the current knowledge regarding the pathophysiology, genetics, and clinical manifestation of these conditions, as well as the approach to diagnosis.<\/jats:p>","DOI":"10.3390\/ijms23105729","type":"journal-article","created":{"date-parts":[[2022,5,20]],"date-time":"2022-05-20T13:56:12Z","timestamp":1653054972000},"page":"5729","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":39,"title":["Recent Insight into the Genetic Basis, Clinical Features, and Diagnostic Methods for Neuronal Ceroid Lipofuscinosis"],"prefix":"10.3390","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7481-2621","authenticated-orcid":false,"given":"Konrad","family":"Kamini\u00f3w","sequence":"first","affiliation":[{"name":"Students\u2019 Scientific Society, Department of Pediatric Neurology, Faculty of Medical Sciences in Katowice, Medical University of Silesia, 40-752 Katowice, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5226-5006","authenticated-orcid":false,"given":"Sylwia","family":"Kozak","sequence":"additional","affiliation":[{"name":"Students\u2019 Scientific Society, Department of Pediatric Neurology, Faculty of Medical Sciences in Katowice, Medical University of Silesia, 40-752 Katowice, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1794-8546","authenticated-orcid":false,"given":"Justyna","family":"Paprocka","sequence":"additional","affiliation":[{"name":"Pediatric Neurology Department, Faculty of Medical Sciences in Katowice, Medical University of Silesia, 40-752 Katowice, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,5,20]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1016\/B978-0-444-59565-2.00038-1","article-title":"Neuronal ceroid lipofuscinoses","volume":"113","author":"Chabrol","year":"2013","journal-title":"Handb. Clin. Neurol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1684\/epd.2016.0844","article-title":"Neuronal ceroid lipofuscinoses","volume":"18","author":"Nita","year":"2016","journal-title":"Epileptic Disord."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S1474-4422(18)30368-5","article-title":"Clinical challenges and future therapeutic approaches for neuronal ceroid lipofuscinosis","volume":"18","author":"Mole","year":"2019","journal-title":"Lancet Neurol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s40265-020-01440-7","article-title":"Neuronal Ceroid Lipofuscinosis: Potential for Targeted Therapy","volume":"81","author":"Specchio","year":"2021","journal-title":"Drugs"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"165570","DOI":"10.1016\/j.bbadis.2019.165570","article-title":"Pathomechanisms in the neuronal ceroid lipofuscinoses","volume":"1866","author":"Nelvagal","year":"2020","journal-title":"Biochim. Biophys. Acta-Mol. Basis Dis."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1016\/j.bbadis.2012.08.012","article-title":"The neuronal ceroid-lipofuscinoses: A historical introduction","volume":"1832","author":"Haltia","year":"2013","journal-title":"Biochim. Biophys. Acta-Mol. Basis Dis."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/nrd.2017.214","article-title":"Emptying the stores: Lysosomal diseases and therapeutic strategies","volume":"17","author":"Platt","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.bbamcr.2008.11.004","article-title":"Neuronal ceroid lipofuscinoses","volume":"1793","author":"Jalanko","year":"2009","journal-title":"Biochim. Biophys. Acta-Mol. Cell Res."},{"key":"ref_9","first-page":"1","article-title":"Lipofuscin in neuronal aging and diseases","volume":"32","author":"Glees","year":"1976","journal-title":"Norm. Pathol. Anat."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1055\/s-2007-973654","article-title":"Neuronal ceroid lipofuscinoses in Scandinavia: Epidemiology and clinical pictures","volume":"28","author":"Uvebrant","year":"1997","journal-title":"Neuropediatrics"},{"key":"ref_11","unstructured":"Rosenberg, R., and Pascual, J. (2015). The neuronal ceroid-lipofuscinoses (Batten disease). Rosenberg\u2019s Molecular and Genetic Basis of Neurological and Psychiatric Disease, Academic Press. [5th ed.]."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1002\/ajmg.1320570206","article-title":"Neuronal ceroid-lipofuscinoses in Italy: An epidemiological study","volume":"57","author":"Cardona","year":"1995","journal-title":"Am. J. Med. Genet."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1016\/j.bbadis.2013.04.008","article-title":"NCL diseases\u2014Clinical perspectives","volume":"1832","author":"Schulz","year":"2013","journal-title":"Biochim. Biophys. Acta-Mol. Basis Dis."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1080\/14712598.2018.1492544","article-title":"Progress in gene and cell therapies for the neuronal ceroid lipofuscinoses","volume":"18","author":"Donsante","year":"2018","journal-title":"Expert Opin. Biol. Ther."},{"key":"ref_15","unstructured":"Gilbert-Barness, E., Barness, L.A., and Farrell, P.M. (2017). Neuronal ceroid-lipofuscinoses. Metabolic Diseases: Foundations of Clinical Management, Genetics, and Pathology, IOS Press BV."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/s41582-019-0138-8","article-title":"Therapeutic landscape for Batten disease: Current treatments and future prospects","volume":"15","author":"Johnson","year":"2019","journal-title":"Nat. Rev. Neurol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s10048-005-0218-3","article-title":"Correlations between genotype, ultrastructural morphology and clinical phenotype in the neuronal ceroid lipofuscinoses","volume":"6","author":"Mole","year":"2005","journal-title":"Neurogenetics"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s00018-010-0468-6","article-title":"Interactions of the proteins of neuronal ceroid lipofuscinosis: Clues to function","volume":"68","author":"Getty","year":"2011","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"2242","DOI":"10.1016\/j.bbadis.2015.04.027","article-title":"Cell biology of the NCL proteins: What they do and don\u2019t do","volume":"1852","author":"Pearce","year":"2015","journal-title":"Biochim. Biophys. Acta-Mol. Basis Dis."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1016\/j.bbadis.2013.03.017","article-title":"Genetic basis and phenotypic correlations of the neuronal ceroid lipofusinoses","volume":"1832","author":"Warrier","year":"2013","journal-title":"Biochim Biophys Acta-Mol. Basis Dis."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Morsy, A., Carmona, A.V., and Trippier, P.C. (2021). Patient-Derived Induced Pluripotent Stem Cell Models for Phenotypic Screening in the Neuronal Ceroid Lipofuscinoses. Molecules, 26.","DOI":"10.3390\/molecules26206235"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1016\/j.bbadis.2012.11.014","article-title":"Human pathology in NCL","volume":"1832","author":"Anderson","year":"2013","journal-title":"Biochim Biophys Acta-Mol. Basis Dis."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1016\/j.bbadis.2015.05.007","article-title":"Human NCL Neuropathology","volume":"1852","author":"Radke","year":"2015","journal-title":"Biochim Biophys Acta-Mol. Basis Dis."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1212\/WNL.0000000000002943","article-title":"Diagnosis and misdiagnosis of adult neuronal ceroid lipofuscinosis (Kufs disease)","volume":"87","author":"Berkovic","year":"2016","journal-title":"Neurology"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s40478-017-0476-y","article-title":"Glial cells are functionally impaired in juvenile neuronal ceroid lipofuscinosis and detrimental to neurons","volume":"5","author":"Parviainen","year":"2017","journal-title":"Acta Neuropathol. Commun."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s40478-018-0575-4","article-title":"Compromised astrocyte function and survival negatively impact neurons in infantile neuronal ceroid lipofuscinosis","volume":"6","author":"Lange","year":"2018","journal-title":"Acta Neuropathol. Commun."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1093\/brain\/awl107","article-title":"Cathepsin D deficiency underlies congenital human neuronal ceroid-lipofuscinosis","volume":"129","author":"Siintola","year":"2006","journal-title":"Brain"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1177\/0883073813494268","article-title":"Classification and natural history of the neuronal ceroid lipofuscinoses","volume":"28","author":"Mink","year":"2013","journal-title":"J. Child Neurol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1080\/15548627.2019.1637200","article-title":"Enzyme replacement therapy with recombinant pro-CTSD (cathepsin D) corrects defective proteolysis and autophagy in neuronal ceroid lipofuscinosis","volume":"16","author":"Marques","year":"2020","journal-title":"Autophagy"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1523\/JNEUROSCI.3081-17.2018","article-title":"Progranulin gene therapy improves lysosomal dysfunction and microglial pathology associated with frontotemporal dementia and neuronal ceroid lipofuscinosis","volume":"38","author":"Arrant","year":"2018","journal-title":"J. Neurosci."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1212\/WNL.0b013e31825f0547","article-title":"New nomenclature and classification scheme for the neuronal ceroid lipofuscinoses","volume":"79","author":"Williams","year":"2012","journal-title":"Neurology"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s13024-018-0300-6","article-title":"Emerging new roles of the lysosome and neuronal ceroid lipofuscinoses","volume":"14","author":"Mukherjee","year":"2019","journal-title":"Mol. Neurodegener."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/s41572-019-0089-9","article-title":"Lysosomal storage diseases","volume":"5","author":"Platt","year":"2019","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"590","DOI":"10.4161\/auto.6259","article-title":"Neurodegenerative lysosomal disorders: A continuum from development to late age","volume":"4","author":"Nixon","year":"2008","journal-title":"Autophagy"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1038\/s41593-018-0221-2","article-title":"Selective vulnerability in neurodegenerative diseases","volume":"21","author":"Fu","year":"2018","journal-title":"Nat. Neurosci."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1006\/nbdi.1999.0267","article-title":"Targeted disruption of the Cln3 gene provides a mouse model for Batten disease. The Batten Mouse Model Consortium [corrected]","volume":"6","author":"Mitchison","year":"1999","journal-title":"Neurobiol. Dis."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"6898","DOI":"10.1523\/JNEUROSCI.20-18-06898.2000","article-title":"Cathepsin D deficiency induces lysosomal storage with ceroid lipofuscin in mouse CNS neurons","volume":"20","author":"Koike","year":"2000","journal-title":"J. Neurosci."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1093\/hmg\/ddt057","article-title":"Atp13a2-deficient mice exhibit neuronal ceroid lipofuscinosis, limited \u03b1-synuclein accumulation and age-dependent sensorimotor deficits","volume":"22","author":"Schultheis","year":"2013","journal-title":"Hum. Mol. Genet."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"13566","DOI":"10.1073\/pnas.251485198","article-title":"Disruption of PPT1 or PPT2 causes neuronal ceroid lipofuscinosis in knockout mice","volume":"98","author":"Gupta","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1086\/338190","article-title":"Mutations in a novel CLN6-encoded transmembrane protein cause variant neuronal ceroid lipofuscinosis in man and mouse","volume":"70","author":"Gao","year":"2002","journal-title":"Am. J. Hum. Genet."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1093\/hmg\/ddh312","article-title":"A mouse model for Finnish variant late infantile neuronal ceroid lipofuscinosis, CLN5, reveals neuropathology associated with early aging","volume":"13","author":"Kopra","year":"2004","journal-title":"Hum. Mol. Genet."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"9117","DOI":"10.1523\/JNEUROSCI.2729-04.2004","article-title":"A mouse model of classical late-infantile neuronal ceroid lipofuscinosis based on targeted disruption of the CLN2 gene results in a loss of tripeptidyl-peptidase I activity and progressive neurodegeneration","volume":"24","author":"Sleat","year":"2004","journal-title":"J. Neurosci."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"311","DOI":"10.2353\/ajpath.2010.090915","article-title":"Accelerated lipofuscinosis and ubiquitination in granulin knockout mice suggest a role for progranulin in successful aging","volume":"177","author":"Ahmed","year":"2010","journal-title":"Am. J. Pathol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1128\/MCB.26.6.2309-2316.2006","article-title":"Murine cathepsin F deficiency causes neuronal lipofuscinosis and late-onset neurological disease","volume":"26","author":"Tang","year":"2006","journal-title":"Mol. Cell. Biol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1002\/acn3.144","article-title":"Mice homozygous for c.451C>T mutation in Cln1 gene recapitulate INCL phenotype","volume":"1","author":"Bouchelion","year":"2014","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1093\/hmg\/ddu428","article-title":"The novel Cln1R151X mouse model of infantile neuronal ceroid lipofuscinosis (INCL) for testing nonsense suppression therapy","volume":"24","author":"Miller","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1093\/hmg\/ddv615","article-title":"Lysosomal dysfunction and impaired autophagy in a novel mouse model deficient for the lysosomal membrane protein Cln7","volume":"25","author":"Brandenstein","year":"2016","journal-title":"Hum. Mol. Genet."},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Geraets, R.D., Langin, L.M., Cain, J.T., Parker, C.M., Beraldi, R., Kovacs, A.D., Weimer, J.M., and Pearce, D.A. (2017). A tailored mouse model of CLN2 disease: A nonsense mutant for testing personalized therapies. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0176526"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.ymgme.2010.04.009","article-title":"A mutation in canine PPT1 causes early onset neuronal ceroid lipofuscinosis in a Dachshund","volume":"100","author":"Sanders","year":"2010","journal-title":"Mol. Genet. Metab."},{"key":"ref_50","first-page":"198042","article-title":"A missense mutation in canine CLN6 in an Australian shepherd with neuronal ceroid lipofuscinosis","volume":"2011","author":"Katz","year":"2011","journal-title":"J. Biomed. Biotechnol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.ymgme.2016.12.007","article-title":"Neuronal ceroid lipofuscinosis (NCL) is caused by the entire deletion of CLN8 in the Alpenl\u00e4ndische Dachsbracke dog","volume":"120","author":"Hirz","year":"2017","journal-title":"Mol. Genet. Metab."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.nbd.2017.08.017","article-title":"Canine neuronal ceroid lipofuscinoses: Promising models for preclinical testing of therapeutic interventions","volume":"108","author":"Katz","year":"2017","journal-title":"Neurobiol. Dis."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1016\/j.bbadis.2015.06.013","article-title":"Recent studies of ovine neuronal ceroid lipofuscinoses from BARN, the Batten Animal Research Network","volume":"1852","author":"Palmer","year":"2015","journal-title":"Biochim. Biophys. Acta-Mol. Basis Dis."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"9891","DOI":"10.1038\/s41598-019-45859-9","article-title":"CRISPR\/Cas9 mediated generation of an ovine model for infantile neuronal ceroid lipofuscinosis (CLN1 disease)","volume":"9","author":"Eaton","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"S81","DOI":"10.1016\/j.ymgme.2018.12.198","article-title":"Characterization of a novel porcine model of CLN3-batten disease","volume":"126","author":"Johnson","year":"2019","journal-title":"Mol. Genet. Metab."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.nbd.2008.06.004","article-title":"Location and connectivity determine GABAergic interneuron survival in the brains of South Hampshire sheep with CLN6 neuronal ceroid lipofuscinosis","volume":"32","author":"Oswald","year":"2008","journal-title":"Neurobiol. Dis."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s002340050427","article-title":"MRI of neuronal ceroid lipofuscinosis. II. Postmortem MRI and histopathological study of the brain in 16 cases of neuronal ceroid lipofuscinosis of juvenile or late infantile type","volume":"39","author":"Autti","year":"1997","journal-title":"Neuroradiology"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.3174\/ajnr.A4816","article-title":"Volumetric Description of Brain Atrophy in Neuronal Ceroid Lipofuscinosis 2: Supratentorial Gray Matter Shows Uniform Disease Progression","volume":"37","author":"Sedlacik","year":"2016","journal-title":"Am. J. Neuroradiol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"376","DOI":"10.3174\/ajnr.A4978","article-title":"MRI Brain Volume Measurements in Infantile Neuronal Ceroid Lipofuscinosis","volume":"38","author":"Baker","year":"2017","journal-title":"Am. J. Neuroradiol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.nbd.2005.05.018","article-title":"Thalamocortical neuron loss and localized astrocytosis in the Cln3Deltaex7\/8 knock-in mouse model of Batten disease","volume":"20","author":"Pontikis","year":"2005","journal-title":"Neurobiol. Dis."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.nbd.2006.09.001","article-title":"Successive neuron loss in the thalamus and cortex in a mouse model of infantile neuronal ceroid lipofuscinosis","volume":"25","author":"Kielar","year":"2007","journal-title":"Neurobiol. Dis."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.nbd.2009.02.001","article-title":"Progressive thalamocortical neuron loss in Cln5 deficient mice: Distinct effects in Finnish variant late infantile NCL","volume":"34","author":"Kielar","year":"2009","journal-title":"Neurobiol. Dis."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.nbd.2012.04.018","article-title":"Selective spatiotemporal patterns of glial activation and neuron loss in the sensory thalamocortical pathways of neuronal ceroid lipofuscinosis 8 mice","volume":"47","author":"Kuronen","year":"2012","journal-title":"Neurobiol. Dis."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"8238","DOI":"10.1523\/JNEUROSCI.4295-15.2016","article-title":"An EEG Investigation of Sleep Homeostasis in Healthy and CLN5 Batten Disease Affected Sheep","volume":"36","author":"Perentos","year":"2016","journal-title":"J. Neurosci."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"e00401","DOI":"10.1002\/brb3.401","article-title":"Molecular neuropathology of the synapse in sheep with CLN5 Batten disease","volume":"5","author":"Amorim","year":"2015","journal-title":"Brain Behav."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"e01096","DOI":"10.1002\/brb3.1096","article-title":"Computed tomography provides enhanced techniques for longitudinal monitoring of progressive intracranial volume loss associated with regional neurodegeneration in ovine neuronal ceroid lipofuscinoses","volume":"8","author":"Russell","year":"2018","journal-title":"Brain Behav."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"E5920","DOI":"10.1073\/pnas.1701832114","article-title":"Synergistic effects of treating the spinal cord and brain in CLN1 disease","volume":"114","author":"Shyng","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"313ra180","DOI":"10.1126\/scitranslmed.aac6191","article-title":"AAV gene transfer delays disease onset in a TPP1-deficient canine model of the late infantile form of Batten disease","volume":"7","author":"Katz","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1002\/ddrr.1118","article-title":"The neuronal ceroid-lipofuscinoses","volume":"17","author":"Bennett","year":"2013","journal-title":"Dev. Disabil. Res. Rev."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1136\/bjophthalmol-2015-307320","article-title":"Novel morphological macular findings in juvenile CLN3 disease","volume":"100","author":"Dulz","year":"2016","journal-title":"Br. J. Ophthalmol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1038\/s41598-017-01716-1","article-title":"Retinal Degeneration in a Mouse Model of CLN5 Disease Is Associated with Compromised Autophagy","volume":"7","author":"Leinonen","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1080\/13816810.2016.1210651","article-title":"Ocular morphology and function in juvenile neuronal ceroid lipofuscinosis (CLN3) in the first decade of life","volume":"38","author":"Preising","year":"2017","journal-title":"Ophthalmic Genet."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/978-3-319-75402-4_50","article-title":"Further Characterization of the Predominant Inner Retinal Degeneration of Aging Cln3\u0394ex7\/8 Knock-In Mice","volume":"1074","author":"Volz","year":"2018","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/2051-5960-2-54","article-title":"Non-invasive assessment of retinal alterations in mouse models of infantile and juvenile neuronal ceroid lipofuscinosis by spectral domain optical coherence tomography","volume":"2","author":"Groh","year":"2014","journal-title":"Acta Neuropathol. Commun."},{"key":"ref_75","doi-asserted-by":"crossref","unstructured":"Follo, C., Ozzano, M., Mugoni, V., Castino, R., Santoro, M., and Isidoro, C. (2011). Knock-down of cathepsin D affects the retinal pigment epithelium, impairs swim-bladder ontogenesis and causes premature death in zebrafish. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0021908"},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Mirza, M., Volz, C., Karlstetter, M., Langiu, M., Somogyi, A., Ruonala, M.O., Tamm, E.R., J\u00e4gle, H., and Langmann, T. (2013). Progressive retinal degeneration and glial activation in the CLN6 (nclf) mouse model of neuronal ceroid lipofuscinosis: A beneficial effect of DHA and curcumin supplementation. PLoS ONE, 8.","DOI":"10.1371\/annotation\/ae907882-62e0-4803-8c00-35b30a649fe9"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"4989","DOI":"10.1167\/iovs.16-20158","article-title":"Retinal Degeneration in Mice Deficient in the Lysosomal Membrane Protein CLN7","volume":"57","author":"Jankowiak","year":"2016","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1101\/lm.034355.114","article-title":"Higher brain functions served by the lowly rodent primary visual cortex","volume":"21","author":"Gavornik","year":"2014","journal-title":"Learn. Mem."},{"key":"ref_79","doi-asserted-by":"crossref","unstructured":"Morgan, J.P., Magee, H., Wong, A., Nelson, T., Koch, B., Cooper, J.D., and Weimer, J.M. (2013). A murine model of variant late infantile ceroid lipofuscinosis recapitulates behavioral and pathological phenotypes of human disease. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0078694"},{"key":"ref_80","doi-asserted-by":"crossref","unstructured":"Thelen, M., Damme, M., Schweizer, M., Hagel, C., Wong, A.M., Cooper, J.D., Braulke, T., and Galliciotti, G. (2012). Disruption of the autophagy-lysosome pathway is involved in neuropathology of the nclf mouse model of neuronal ceroid lipofuscinosis. PLoS ONE, 7.","DOI":"10.1371\/annotation\/a4b06d46-8eb9-4d15-a15a-41bf4b5ccb8b"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1212\/WNL.0b013e31821435bd","article-title":"Cardiac involvement in juvenile neuronal ceroid lipofuscinosis (Batten disease)","volume":"76","author":"Ostergaard","year":"2011","journal-title":"Neurology"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.ymgme.2016.05.008","article-title":"Neuronal ceroid lipofuscinosis associated with an MFSD8 mutation in Chihuahuas","volume":"118","author":"Ashwini","year":"2016","journal-title":"Mol. Genet. Metab."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/gt.2017.4","article-title":"Extraneuronal pathology in a canine model of CLN2 neuronal ceroid lipofuscinosis after intracerebroventricular gene therapy that delays neurological disease progression","volume":"24","author":"Katz","year":"2017","journal-title":"Gene Ther."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.autneu.2018.07.003","article-title":"Paroxysmal sympathetic hyperactivity in Juvenile neuronal ceroid lipofuscinosis (Batten disease)","volume":"214","author":"Ostergaard","year":"2018","journal-title":"Auton. Neurosci."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.yexmp.2014.10.003","article-title":"Neuronal ceroid lipofuscinosis genes, CLN2, CLN3 and CLN5 are spatially and temporally co-expressed in a developing mouse brain","volume":"97","author":"Fabritius","year":"2014","journal-title":"Exp. Mol. Pathol."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.dib.2016.06.027","article-title":"Data on characterizing the gene expression patterns of neuronal ceroid lipofuscinosis genes: CLN1, CLN2, CLN3, CLN5 and their association to interneuron and neurotransmission markers: Parvalbumin and Somatostatin","volume":"8","author":"Minye","year":"2016","journal-title":"Data Brief."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.brainresbull.2012.03.003","article-title":"Mouse models of neuronal ceroid lipofuscinoses: Useful pre-clinical tools to delineate disease pathophysiology and validate therapeutics","volume":"88","author":"Shacka","year":"2012","journal-title":"Brain Res. Bull."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.1016\/j.bbadis.2015.05.014","article-title":"Towards a new understanding of NCL pathogenesis","volume":"1852","author":"Cooper","year":"2015","journal-title":"Biochim. Biophys. Acta-Mol. Basis Dis."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1002\/mds.25669","article-title":"Neurophysiology of gait: From the spinal cord to the frontal lobe","volume":"28","author":"Takakusaki","year":"2013","journal-title":"Mov. Disord."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1016\/j.bbadis.2015.04.022","article-title":"The neuronal ceroid lipofuscinoses: Opportunities from model systems","volume":"1852","author":"Faller","year":"2015","journal-title":"Biochim Biophys Acta-Mol. Basis Dis."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.nbd.2015.08.005","article-title":"The interneuron energy hypothesis: Implications for brain disease","volume":"90","author":"Kann","year":"2016","journal-title":"Neurobiol. Dis."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1042\/BST0381436","article-title":"Lysosomal compromise and brain dysfunction: Examining the role of neuroaxonal dystrophy","volume":"38","author":"Walkley","year":"2010","journal-title":"Biochem. Soc. Trans."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/cns.12330","article-title":"Degeneration and regeneration of GABAergic interneurons in the dentate gyrus of adult mice in experimental models of epilepsy","volume":"21","author":"Wei","year":"2015","journal-title":"CNS Neurosci. Ther."},{"key":"ref_94","first-page":"205","article-title":"Inhibitory interneurons in Alzheimer\u2019s disease","volume":"119","author":"Vargova","year":"2018","journal-title":"Bratisl. Lek. Listy"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"14972","DOI":"10.1038\/s41598-017-14966-w","article-title":"TDP-43 accelerates age-dependent degeneration of interneurons","volume":"7","author":"Tsuiji","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.neubiorev.2018.05.021","article-title":"A new outlook on cholinergic interneurons in Parkinson\u2019s disease and L-DOPA-induced dyskinesia","volume":"92","author":"Conti","year":"2018","journal-title":"Neurosci. Biobehav. Rev."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.neurobiolaging.2008.06.011","article-title":"Inflammatory changes are tightly associated with neurodegeneration in the brain and spinal cord of the APP\/PS1KI mouse model of Alzheimer\u2019s disease","volume":"31","author":"Wirths","year":"2010","journal-title":"Neurobiol. Aging"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1016\/j.bbadis.2013.05.014","article-title":"NCL disease mechanisms","volume":"1832","author":"Palmer","year":"2013","journal-title":"Biochim Biophys Acta-Mol. Basis Dis."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"417","DOI":"10.3389\/fnins.2015.00417","article-title":"Neuroinflammatory paradigms in lysosomal storage diseases","volume":"9","author":"Bosch","year":"2015","journal-title":"Front. Neurosci."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s13024-017-0192-x","article-title":"Glial contributions to neurodegeneration in tauopathies","volume":"12","author":"Leyns","year":"2017","journal-title":"Mol. Neurodegener."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1146\/annurev-physiol-022516-034406","article-title":"Microglia in Physiology and Disease","volume":"79","author":"Wolf","year":"2017","journal-title":"Annu. Rev. Physiol."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1093\/brain\/awt020","article-title":"Immune cells perturb axons and impair neuronal survival in a mouse model of infantile neuronal ceroid lipofuscinosis","volume":"136","author":"Groh","year":"2013","journal-title":"Brain"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1002\/glia.22962","article-title":"Sialoadhesin promotes neuroinflammation-related disease progression in two mouse models of CLN disease","volume":"64","author":"Groh","year":"2016","journal-title":"Glia"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.jneuroim.2010.08.024","article-title":"Immunosuppression alters disease severity in juvenile Batten disease mice","volume":"230","author":"Seehafer","year":"2011","journal-title":"J. Neuroimmunol."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.nbd.2018.05.015","article-title":"Lysosome trafficking and signaling in health and neurodegenerative diseases","volume":"122","author":"Lie","year":"2019","journal-title":"Neurobiol. Dis."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1083\/jcb.201607005","article-title":"The lysosome as a command-and-control center for cellular metabolism","volume":"214","author":"Lim","year":"2016","journal-title":"J. Cell Biol."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/s41598-018-36379-z","article-title":"Autophagy-lysosome pathway alterations and alpha-synuclein up-regulation in the subtype of neuronal ceroid lipofuscinosis, CLN5 disease","volume":"9","author":"Adams","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.nbd.2017.01.001","article-title":"Characterisation of early changes in ovine CLN5 and CLN6 Batten disease neural cultures for the rapid screening of therapeutics","volume":"100","author":"Best","year":"2017","journal-title":"Neurobiol. Dis."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.bbalip.2016.01.006","article-title":"Autophagy, lipophagy and lysosomal lipid storage disorders","volume":"1861","author":"Ward","year":"2016","journal-title":"Biochim. Biophys. Acta-Mol. Cell Biol. Lipids"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"719","DOI":"10.4161\/auto.19469","article-title":"Autophagy in lysosomal storage disorders","volume":"8","author":"Lieberman","year":"2012","journal-title":"Autophagy"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1089\/ars.2011.4405","article-title":"Lysosomal function and dysfunction: Mechanism and disease","volume":"17","author":"Boya","year":"2012","journal-title":"Antioxid. Redox Signal."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"12412","DOI":"10.1038\/s41598-017-12603-0","article-title":"Proteomic mapping of differentially vulnerable pre-synaptic populations identifies regulators of neuronal stability in vivo","volume":"7","author":"Fuller","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"e40316","DOI":"10.7554\/eLife.40316","article-title":"Developmental NMDA receptor dysregulation in the infantile neuronal ceroid lipofuscinosis mouse model","volume":"8","author":"Koster","year":"2019","journal-title":"eLife"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1093\/hmg\/10.1.69","article-title":"Palmitoyl protein thioesterase (PPT) localizes into synaptosomes and synaptic vesicles in neurons: Implications for infantile neuronal ceroid lipofuscinosis (INCL)","volume":"10","author":"Lehtovirta","year":"2001","journal-title":"Hum. Mol. Genet."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.15252\/embj.201591125","article-title":"Regulation of synaptic activity by snapin-mediated endolysosomal transport and sorting","volume":"34","author":"Sheng","year":"2015","journal-title":"EMBO J."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1083\/jcb.201704068","article-title":"Activity-dependent trafficking of lysosomes in dendrites and dendritic spines","volume":"216","author":"Goo","year":"2017","journal-title":"J. Cell Biol."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/j.neuron.2017.01.026","article-title":"Bassoon Controls Presynaptic Autophagy through Atg5","volume":"93","author":"Okerlund","year":"2017","journal-title":"Neuron"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1124\/pr.116.013342","article-title":"Synaptic Vesicle-Recycling Machinery Components as Potential Therapeutic Targets","volume":"69","author":"Li","year":"2017","journal-title":"Pharmacol. Rev."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1113\/JP270988","article-title":"Role of astrocyte-synapse interactions in CNS disorders","volume":"595","author":"Caldwell","year":"2017","journal-title":"J. Physiol."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1146\/annurev-immunol-051116-052358","article-title":"Microglia Function in the Central Nervous System During Health and Neurodegeneration","volume":"35","author":"Colonna","year":"2017","journal-title":"Annu. Rev. Immunol."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1007\/s00221-017-4928-1","article-title":"Astrocytes and synaptic plasticity in health and disease","volume":"235","author":"Singh","year":"2017","journal-title":"Exp. Brain Res."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/nrm3565","article-title":"Signals from the lysosome: A control centre for cellular clearance and energy metabolism","volume":"14","author":"Settembre","year":"2013","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1146\/annurev-neuro-070815-014031","article-title":"Brain Disorders Due to Lysosomal Dysfunction","volume":"39","author":"Fraldi","year":"2016","journal-title":"Annu. Rev. Neurosci."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1146\/annurev-neuro-080317-061804","article-title":"Lysosomes and Brain Health","volume":"41","author":"Sharma","year":"2018","journal-title":"Annu. Rev. Neurosci."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"14612","DOI":"10.1038\/ncomms14612","article-title":"Misrouting of v-ATPase subunit V0a1 dysregulates lysosomal acidification in a neurodegenerative lysosomal storage disease model","volume":"8","author":"Bagh","year":"2017","journal-title":"Nat. Commun."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1093\/hmg\/ddy076","article-title":"Loss of CLN7 results in depletion of soluble lysosomal proteins and impaired mTOR reactivation","volume":"27","author":"Danyukova","year":"2018","journal-title":"Hum. Mol. Genet."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s13024-016-0114-3","article-title":"Trehalose upregulates progranulin expression in human and mouse models of GRN haploinsufficiency: A novel therapeutic lead to treat frontotemporal dementia","volume":"11","author":"Holler","year":"2016","journal-title":"Mol. Neurodegener."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"14338","DOI":"10.1038\/ncomms14338","article-title":"mTORC1-independent TFEB activation via Akt inhibition promotes cellular clearance in neurodegenerative storage diseases","volume":"8","author":"Palmieri","year":"2017","journal-title":"Nat. Commun."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1016\/j.bbadis.2015.05.011","article-title":"Genetics of the neuronal ceroid lipofuscinoses (Batten disease)","volume":"1852","author":"Mole","year":"2015","journal-title":"Biochim. Biophys. Acta-Mol. Basis Dis."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.cellsig.2017.11.001","article-title":"Cln5 is secreted and functions as a glycoside hydrolase in Dictyostelium","volume":"42","author":"Huber","year":"2018","journal-title":"Cell. Signal."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1177\/0883073813494813","article-title":"Neurobehavioral features and natural history of juvenile neuronal ceroid lipofuscinosis (Batten disease)","volume":"28","author":"Adams","year":"2013","journal-title":"J. Child. Neurol."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1002\/ajmg.10660","article-title":"Late infantile neuronal ceroid lipofuscinosis: Quantitative description of the clinical course in patients with CLN2 mutations","volume":"112","author":"Steinfeld","year":"2002","journal-title":"Am. J. Med. Genet."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.cct.2013.04.004","article-title":"Methodology of clinical research in rare diseases: Development of a research program in juvenile neuronal ceroid lipofuscinosis (JNCL) via creation of a patient registry and collaboration with patient advocates","volume":"35","author":"Augustine","year":"2013","journal-title":"Contemp. Clin. Trials."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/S2352-4642(18)30179-2","article-title":"Disease characteristics and progression in patients with late-infantile neuronal ceroid lipofuscinosis type 2 (CLN2) disease: An observational cohort study","volume":"2","author":"Nickel","year":"2018","journal-title":"Lancet Child. Adolesc. Health"},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1111\/dmcn.13473","article-title":"Phenotype and natural history of variant late infantile ceroid-lipofuscinosis 5","volume":"59","author":"Simonati","year":"2017","journal-title":"Dev. Med. Child. Neurol."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1056\/NEJMoa1712649","article-title":"Study of Intraventricular Cerliponase Alfa for CLN2 Disease","volume":"378","author":"Schulz","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1212\/WNL.0000000000001784","article-title":"Electroclinical spectrum of the neuronal ceroid lipofuscinoses associated with CLN6 mutations","volume":"85","author":"Canafoglia","year":"2015","journal-title":"Neurology"},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1136\/jcp.2005.027045","article-title":"Blood film examination for vacuolated lymphocytes in the diagnosis of metabolic disorders; retrospective experience of more than 2500 cases from a single centre","volume":"58","author":"Anderson","year":"2005","journal-title":"J. Clin. Pathol."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"811686","DOI":"10.3389\/fneur.2022.811686","article-title":"Neuronal Ceroid Lipofuscinosis: The Multifaceted Approach to the Clinical Issues, an Overview","volume":"13","author":"Simonati","year":"2022","journal-title":"Front. Neurol."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.ijcard.2014.03.159","article-title":"Severe sinus node dysfunction in a patient with juvenile neuronal ceroid lipofuscinosis","volume":"174","author":"Dilaveris","year":"2014","journal-title":"Int. J. Cardiol."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.pediatrneurol.2017.01.034","article-title":"Management Strategies for CLN2 Disease","volume":"69","author":"Williams","year":"2017","journal-title":"Pediatr. Neurol."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1111\/dmcn.12634","article-title":"Standardized assessment of seizures in patients with juvenile neuronal ceroid lipofuscinosis","volume":"57","author":"Augustine","year":"2015","journal-title":"Dev. Med. Child. Neurol."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1055\/s-0036-1579784","article-title":"Considering Valproate as a Risk Factor for Rapid Exacerbation of Complex Movement Disorder in Progressed Stages of Late-Infantile CLN2 Disease","volume":"47","author":"Johannsen","year":"2016","journal-title":"Neuropediatrics"},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.ymgme.2016.07.011","article-title":"Diagnosis of neuronal ceroid lipofuscinosis type 2 (CLN2 disease): Expert recommendations for early detection and laboratory diagnosis","volume":"119","author":"Fietz","year":"2016","journal-title":"Mol. Genet. Metab."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"2952","DOI":"10.1016\/j.ajpath.2011.08.036","article-title":"Central nervous system fibrosis is associated with fibrocyte-like infiltrates","volume":"179","author":"Aldrich","year":"2011","journal-title":"Am. J. Pathol."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1111\/j.1399-0004.2009.01214.x","article-title":"An integrated strategy for the diagnosis of neuronal ceroid lipofuscinosis types 1 (CLN1) and 2 (CLN2) in eleven Latin American patients","volume":"76","author":"Kohan","year":"2009","journal-title":"Clin. Genet."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1016\/j.bbadis.2015.05.003","article-title":"The neuronal ceroid lipofuscinoses program: A translational research experience in Argentina","volume":"1852","author":"Kohan","year":"2015","journal-title":"Biochim. Biophys. Acta-Mol. Basis Dis."},{"key":"ref_148","doi-asserted-by":"crossref","unstructured":"Pati\u00f1o, L.C., Battu, R., Ortega-Recalde, O., Nallathambi, J., Anandula, V.R., Renukaradhya, U., and Laissue, P. (2014). Exome sequencing is an efficient tool for variant late-infantile neuronal ceroid lipofuscinosis molecular diagnosis. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0109576"},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s00401-008-0426-7","article-title":"Novel mutation and the first prenatal screening of cathepsin D deficiency (CLN10)","volume":"117","author":"Fritchie","year":"2009","journal-title":"Acta Neuropathol."},{"key":"ref_150","unstructured":"Mole, S.E., and Williams, R.E. (2022, May 16). Neuronal ceroid-lipofuscinoses, GeneReviews, Available online: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK1428."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0301-2115(98)00333-9","article-title":"A novel assay for lysosomal pepstatin-insensitive proteinase and its application for the diagnosis of late-infantile neuronal ceroid lipofuscinosis","volume":"281","author":"Junaid","year":"1999","journal-title":"Clin. Chim. Acta"},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1006\/mgme.1999.2809","article-title":"A rapid fluorogenic palmitoyl-protein thioesterase assay: Pre-and postnatal diagnosis of INCL","volume":"66","author":"Keulemans","year":"1999","journal-title":"Mol. Genet. Metab."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1136\/jmg.36.6.471","article-title":"A new simple enzyme assay for pre-and postnatal diagnosis of infantile neuronal ceroid lipofuscinosis (INCL) and its variants","volume":"36","author":"Voznyi","year":"1999","journal-title":"J. Med. Genet."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0014-5793(98)01683-4","article-title":"Classical late infantile neuronal ceroid lipofuscinosis fibroblasts are deficient in lysosomal tripeptidyl peptidase I","volume":"443","author":"Vines","year":"1999","journal-title":"FEBS Lett."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1093\/clinchem\/46.7.1005","article-title":"Enzyme-based diagnosis of classical late infantile neuronal ceroid lipofuscinosis: Comparison of tripeptidyl peptidase I and pepstatin-insensitive protease assays","volume":"46","author":"Sohar","year":"2000","journal-title":"Clin. Chem."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1042\/bj20021226","article-title":"A replacement of the active-site aspartic acid residue 293 in mouse cathepsin D affects its intracellular stability, processing and transport in HEK-293 cells","volume":"369","author":"Partanen","year":"2003","journal-title":"Biochem. J."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/j.1750-3639.1998.tb00140.x","article-title":"Extracerebral biopsy in lysosomal and peroxisomal disorders. Ultrastructural findings","volume":"8","author":"Martin","year":"1998","journal-title":"Brain Pathol."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.bbadis.2006.07.001","article-title":"Diagnosis of the neuronal ceroid lipofuscinoses: An update","volume":"1762","author":"Williams","year":"2006","journal-title":"Biochim. Biophys. Acta-Mol. Basis Dis."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.3174\/ajnr.A4669","article-title":"Brain Region-Specific Degeneration with Disease Progression in Late Infantile Neuronal Ceroid Lipofuscinosis (CLN2 Disease)","volume":"37","author":"Dyke","year":"2016","journal-title":"Am. J. Neuroradiol."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1111\/epi.13820","article-title":"Photosensitivity is an early marker of neuronal ceroid lipofuscinosis type 2 disease","volume":"58","author":"Specchio","year":"2017","journal-title":"Epilepsia"},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1177\/0883073816658659","article-title":"Unique Characteristics of the Photoparoxysmal Response in Patients with Neuronal Ceroid Lipofuscinosis Type 2: Can EEG Be a Biomarker?","volume":"31","author":"Albert","year":"2016","journal-title":"J. Child. Neurol."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1684\/epd.2017.0911","article-title":"Long-term follow-up of two siblings with adult-onset neuronal ceroid lipofuscinosis, Kufs type A","volume":"19","author":"Alpaslan","year":"2017","journal-title":"Epileptic Disord."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"e0299","DOI":"10.1097\/MD.0000000000010299","article-title":"Occipital epilepsy versus progressive myoclonic epilepsy in a patient with continuous occipital spikes and photosensitivity in electroencephalogram: A case report","volume":"97","author":"Lv","year":"2018","journal-title":"Medicine"},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1136\/jnnp.40.4.323","article-title":"So-called neuronal ceroid lipofuscinosis","volume":"40","author":"Pampiglione","year":"1977","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"845877","DOI":"10.3389\/fneur.2022.845877","article-title":"Neurophysiological Findings in Neuronal Ceroid Lipofuscinoses","volume":"13","author":"Trivisano","year":"2022","journal-title":"Front. Neurol."},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1111\/dmcn.14346","article-title":"Paediatric-onset neuronal ceroid lipofuscinosis: First symptoms and presentation at diagnosis","volume":"62","author":"Nasser","year":"2020","journal-title":"Dev. Med. Child. Neurol."},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.eplepsyres.2018.05.005","article-title":"Late-onset childhood neuronal ceroid lipofuscinosis: Early clinical and electroencephalographic markers","volume":"144","author":"Valenzuela","year":"2018","journal-title":"Epilepsy Res."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1111\/epi.14031","article-title":"Photosensitivity as an early marker of epileptic and developmental encephalopathies","volume":"59","author":"Mastrangelo","year":"2018","journal-title":"Epilepsia"},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"2438","DOI":"10.1038\/s41433-021-01594-y","article-title":"An ERG and OCT study of neuronal ceroid lipofuscinosis CLN2 Battens retinopathy","volume":"35","author":"Thompson","year":"2021","journal-title":"Eye"},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.pediatrneurol.2008.10.018","article-title":"Variant late infantile neuronal ceroid lipofuscinosis because of CLN1 mutations","volume":"40","author":"Simonati","year":"2009","journal-title":"Pediatr. Neurol."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1212\/WNL.55.4.579","article-title":"Phenotype-genotype correlation in eight patients with Finnish variant late infantile NCL (CLN5)","volume":"55","author":"Holmberg","year":"2000","journal-title":"Neurology"},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.pediatrneurol.2013.08.008","article-title":"Clinical, electrophysiological, imaging, and ultrastructural description in 68 patients with neuronal ceroid lipofuscinoses and its subtypes","volume":"50","author":"Jadav","year":"2014","journal-title":"Pediatr. Neurol."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"215","DOI":"10.5935\/0004-2749.20170053","article-title":"Retinal function in patients with the neuronal ceroid lipofuscinosis phenotype","volume":"80","author":"Quagliato","year":"2017","journal-title":"Arq. Bras. Oftalmol."},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.rbmo.2013.04.011","article-title":"Successful PGD for late infantile neuronal ceroid lipofuscinosis achieved by combined chromosome and TPP1 gene analysis","volume":"27","author":"Shen","year":"2013","journal-title":"Reprod. Biomed. Online"},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/0387-7604(95)00012-Z","article-title":"Prenatal diagnosis of infantile neuronal ceroid-lipofuscinosis: A combined electron microscopic and molecular genetic approach","volume":"17","author":"Goebel","year":"1995","journal-title":"Brain Dev."},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/j.1750-3639.1998.tb00141.x","article-title":"Prenatal diagnosis of lysosomal storage diseases","volume":"8","author":"Lake","year":"1998","journal-title":"Brain Pathol."},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/S0140-6736(96)90148-8","article-title":"Prenatal diagnosis of Batten\u2019s disease","volume":"347","author":"Munroe","year":"1996","journal-title":"Lancet"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/23\/10\/5729\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T23:15:33Z","timestamp":1760138133000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/23\/10\/5729"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,20]]},"references-count":177,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2022,5]]}},"alternative-id":["ijms23105729"],"URL":"https:\/\/doi.org\/10.3390\/ijms23105729","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,20]]}}}